Events
Catalyst Pharmaceuticals, Inc. announced that it will participate in the 2019 Cantor Global Healthcare Conference in New York, NY.
Menarini Silicon Biosystems will host a symposium on the importance of liquid biopsy and circulating tumor cells (CTCs) in advancing precision medicine for patients with metastatic breast and prostate cancer.
Global Blood Therapeutics, Inc. announced that it will present at the 2019 Cantor Global Healthcare Conference in New York City on Wednesday, October 2, 2019, at 10:05 a.m. Eastern Time.
Neos Therapeutics, Inc. announced that Jerry McLaughlin, chief executive officer, will present a company overview at the upcoming Cantor Fitzgerald Global Healthcare Conference on Wednesday, October 2, 2019 at 9:30 a.m. ET in New York, NY.
Meetings with Growth-Oriented Investors, September 27-29, 2019
Summit Therapeutics plc announces that it will host a research and development day for investors and media on 7 October 2019 from 8am-12pm EDT in New York City.
Biocrates Life Sciences AG, the global leader in targeted metabolomics, and Helmholtz Zentrum München, the German Research Center for Environmental Health, enter a new phase of collaboration in their 10-year partnership.
Hutchison China MediTech Limited will showcase data from its proprietary clinical programs at the 2019 European Society for Medical Oncology Congress on September 27 to October 1, 2019 in Barcelona, Spain.
As more gene therapies advance to clinical trials, participants will discuss which are the best strategies for manufacturing to scale
Eisai Co., Ltd. announced that a series of abstracts will be presented during the European Society for Medical Oncology 2019 Congress taking place in Barcelona, Spain, from September 27 to October 1, 2019.
PRESS RELEASES